AND.TO Quote, Financials, Valuation and Earnings

Canadian National Railway has a net margin of 10.2% compared to Andlauer Healthcare Group's net margin of 26.4%. Andlauer Healthcare Group's return on equity of 14.67% beat Canadian National Railway's return on equity of 27.49%.

Andlauer Healthcare Group has a consensus price target of --, signalling upside risk potential of 8.62%. On the other hand Canadian National Railway has an analysts' consensus of $172.81 which suggests that it could grow by 15.31%. Given that Canadian National Railway has higher upside potential than Andlauer Healthcare Group, analysts believe Canadian National Railway is more attractive than Andlauer Healthcare Group.

Andlauer Healthcare Group has a beta of 0.677, which suggesting that the stock is 32.303% less volatile than S&P 500. In comparison Canadian National Railway has a beta of 0.695, suggesting its less volatile than the S&P 500 by 30.525%.

Andlauer Healthcare Group has a quarterly dividend of $0.11 per share corresponding to a yield of 0.96%. Canadian National Railway offers a yield of 2.26% to investors and pays a quarterly dividend of $0.85 per share. Andlauer Healthcare Group pays 21.47% of its earnings as a dividend. Canadian National Railway pays out 36.82% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Andlauer Healthcare Group quarterly revenues are $159.6M, which are smaller than Canadian National Railway quarterly revenues of $4.1B. Andlauer Healthcare Group's net income of $16.3M is lower than Canadian National Railway's net income of $1.1B. Notably, Andlauer Healthcare Group's price-to-earnings ratio is 27.68x while Canadian National Railway's PE ratio is 17.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Andlauer Healthcare Group is 2.79x versus 5.58x for Canadian National Railway. Usually stocks with elevated PS ratios are considered overvalued.

Canadian Pacific Kansas City has a net margin of 10.2% compared to Andlauer Healthcare Group's net margin of 23.58%. Andlauer Healthcare Group's return on equity of 14.67% beat Canadian Pacific Kansas City's return on equity of 8.11%.

Andlauer Healthcare Group has a consensus price target of --, signalling upside risk potential of 8.62%. On the other hand Canadian Pacific Kansas City has an analysts' consensus of $127.20 which suggests that it could grow by 14.8%. Given that Canadian Pacific Kansas City has higher upside potential than Andlauer Healthcare Group, analysts believe Canadian Pacific Kansas City is more attractive than Andlauer Healthcare Group.

Andlauer Healthcare Group has a beta of 0.677, which suggesting that the stock is 32.303% less volatile than S&P 500. In comparison Canadian Pacific Kansas City has a beta of 0.809, suggesting its less volatile than the S&P 500 by 19.099%.

Andlauer Healthcare Group has a quarterly dividend of $0.11 per share corresponding to a yield of 0.96%. Canadian Pacific Kansas City offers a yield of 0.69% to investors and pays a quarterly dividend of $0.19 per share. Andlauer Healthcare Group pays 21.47% of its earnings as a dividend. Canadian Pacific Kansas City pays out 18% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Andlauer Healthcare Group quarterly revenues are $159.6M, which are smaller than Canadian Pacific Kansas City quarterly revenues of $3.5B. Andlauer Healthcare Group's net income of $16.3M is lower than Canadian Pacific Kansas City's net income of $837M. Notably, Andlauer Healthcare Group's price-to-earnings ratio is 27.68x while Canadian Pacific Kansas City's PE ratio is 29.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Andlauer Healthcare Group is 2.79x versus 7.17x for Canadian Pacific Kansas City. Usually stocks with elevated PS ratios are considered overvalued.

Mullen Group has a net margin of 10.2% compared to Andlauer Healthcare Group's net margin of 7.21%. Andlauer Healthcare Group's return on equity of 14.67% beat Mullen Group's return on equity of 12.45%.

Andlauer Healthcare Group has a consensus price target of --, signalling upside risk potential of 8.62%. On the other hand Mullen Group has an analysts' consensus of $19.10 which suggests that it could grow by 29.84%. Given that Mullen Group has higher upside potential than Andlauer Healthcare Group, analysts believe Mullen Group is more attractive than Andlauer Healthcare Group.

Andlauer Healthcare Group has a beta of 0.677, which suggesting that the stock is 32.303% less volatile than S&P 500. In comparison Mullen Group has a beta of 1.730, suggesting its more volatile than the S&P 500 by 73.021%.

Andlauer Healthcare Group has a quarterly dividend of $0.11 per share corresponding to a yield of 0.96%. Mullen Group offers a yield of 5.24% to investors and pays a quarterly dividend of $0.07 per share. Andlauer Healthcare Group pays 21.47% of its earnings as a dividend. Mullen Group pays out 47.38% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Andlauer Healthcare Group quarterly revenues are $159.6M, which are smaller than Mullen Group quarterly revenues of $532M. Andlauer Healthcare Group's net income of $16.3M is lower than Mullen Group's net income of $38.4M. Notably, Andlauer Healthcare Group's price-to-earnings ratio is 27.68x while Mullen Group's PE ratio is 10.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Andlauer Healthcare Group is 2.79x versus 0.72x for Mullen Group. Usually stocks with elevated PS ratios are considered overvalued.

TFI International has a net margin of 10.2% compared to Andlauer Healthcare Group's net margin of 5.86%. Andlauer Healthcare Group's return on equity of 14.67% beat TFI International's return on equity of 18.18%.

Andlauer Healthcare Group has a consensus price target of --, signalling upside risk potential of 8.62%. On the other hand TFI International has an analysts' consensus of $221.06 which suggests that it could grow by 16.06%. Given that TFI International has higher upside potential than Andlauer Healthcare Group, analysts believe TFI International is more attractive than Andlauer Healthcare Group.

Andlauer Healthcare Group has a beta of 0.677, which suggesting that the stock is 32.303% less volatile than S&P 500. In comparison TFI International has a beta of 1.384, suggesting its more volatile than the S&P 500 by 38.445%.

Andlauer Healthcare Group has a quarterly dividend of $0.11 per share corresponding to a yield of 0.96%. TFI International offers a yield of 1.18% to investors and pays a quarterly dividend of $0.65 per share. Andlauer Healthcare Group pays 21.47% of its earnings as a dividend. TFI International pays out 23.99% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Andlauer Healthcare Group quarterly revenues are $159.6M, which are smaller than TFI International quarterly revenues of $3B. Andlauer Healthcare Group's net income of $16.3M is lower than TFI International's net income of $174.6M. Notably, Andlauer Healthcare Group's price-to-earnings ratio is 27.68x while TFI International's PE ratio is 25.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Andlauer Healthcare Group is 2.79x versus 1.46x for TFI International. Usually stocks with elevated PS ratios are considered overvalued.